zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2023 / Oneness received Medical Devices Export License approvals by TFDA on Bonvadis Topical Cream and Bonvadis Cream. The certificate will be collected accordingly.

Oneness received Medical Devices Export License approvals by TFDA on Bonvadis Topical Cream and Bonvadis Cream. The certificate will be collected accordingly.

2023-03-22

Published Date:2023-03-22

Original Link:https://www.onenessbio.com/en/news_detail210_4.htm

No 1 Date of announcement 2023/03/22 Time of announcement 18:32:02
Subject Oneness received Medical Devices Export License approvals by TFDA on Bonvadis Topical Cream and Bonvadis Cream. The certificate will be collected accordingly.
To which item it meets paragraph 53 Date of events 2023/03/22
Statement
  1. Date of occurrence of the event:2023/03/22
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or  ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:The Medical Device Export Licenses approvals issued by the Taiwan Food and Drug Administration (TFDA) on Bonvadis Topical Cream (Wound management device) and Bonvadis Cream (Scar management device) had been received today under approval numbers in 001745 and 001746, respectively.
  6. Countermeasures:None.
  7. Any other matters that need to be specified(the information  disclosure also meets the requirements of Article 7, subparagraph 9  of the Securities and Exchange Act Enforcement Rules, which brings  forth a significant impact on shareholders rights or the price of  the securities on public companies.):None.